Showing results (1541-1550 of 1,708) with videos related to

Sort By:
Pageof 171
European Journal of Heart Failure|October 6, 2017
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trialPhillip H Lam, Daniel J Dooley, Gregg C Fonarow, et al.
Circulation|August 16, 2020
Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58Marc P Bonaca, Stephen D Wiviott, Thomas A Zelniker, et al.
JACC. Cardiovascular Interventions|February 19, 2025
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCIVijay Kunadian, Mauro Gitto, Birgit Vogel, et al.
Circulation|March 18, 2020
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)Kevin R Bainey, Robert C Welsh, Stuart J Connolly, et al.
Circulation. Cardiovascular Interventions|February 6, 2020
Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA TrialFaisal Latif, Lauren Uyeda, Robert Edson, et al.
European Heart Journal|December 8, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsFrancesco Costa, Claudio Montalto, Mattia Branca, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
Journal of the American College of Cardiology|October 7, 2017
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection FractionPhillip H Lam, Daniel J Dooley, Prakash Deedwania, et al.
Pageof 171